NDC 53329-601-28 - Medline
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 53329-601
- Requested NDC
- 53329-601-28
- Package NDCs from labels
- 53329-601-28, 53329-601-09
- Manufacturer
- Medline Industries, LP
- Effective date
- 2026-08-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Medline - Medline Industries, LP | Medline Industries, LP | 2026-08-28 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aspirin Low Dose | ASPIRIN | Strategic Sourcing Services LLC | 3c7883da-6f51-4716-b012-0e33d239a60e | 2026-11-06 | Warnings | R16CO5Y76E |
| Aspirin Low Dose | ASPIRIN | L.N.K. International, Inc. | 39e142a7-8590-4e1e-8319-6904fb57cc8a | 2026-11-05 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Bi-Mart | cc5db55a-a2b0-48f4-802b-9e5e94fd9ceb | 2026-11-05 | Warnings | R16CO5Y76E |
| CARDIASPIRIN PROTECT | ASPIRIN | OPMX LLC | 03774690-662b-1c30-e063-6294a90a3488 | 2026-11-04 | Warnings | R16CO5Y76E |
| Dolex Forte | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Pharmadel LLC | 3c2d90fc-130d-476c-e063-6294a90a8c15 | 2026-11-03 | Warnings | R16CO5Y76E |
| equate aspirin chewable | ASPIRIN | Wal-Mart Stores Inc | 9147c0ce-fcdb-457c-b9f5-e4edd66e91d0 | 2026-11-01 | Warnings | R16CO5Y76E |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | LEADER/ Cardinal Health 110, Inc. | b3773f02-02a9-33c8-e053-2995a90a2235 | 2026-10-30 | Warnings | R16CO5Y76E |
| Anti Nausea Liquid Cherry Flavor | DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 743b215a-81cc-408c-9375-4f427161a05b | 2026-10-30 | Warnings | IY9XDZ35W2 |
| Adult Low Dose Aspirin | ASPIRIN | HYVEE INC | 45ae4509-fb50-66fd-e063-6294a90a2d7b | 2026-10-28 | Warnings | R16CO5Y76E |
| Gencare-Aspirin Low Dose Pain reliever (NSAID) | ASPIRIN | Pioneer Life Sciences, LLC | 24d4f46a-c7a5-4e94-804f-1e307d8e8cfc | 2026-10-28 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Chain Drug Marketing Association, Inc. | 2d375ec9-a528-4048-a15b-652fa20e74a7 | 2026-10-28 | Warnings | R16CO5Y76E |
| Aspirin Enteric Coated | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION INC | f1ce15a3-9824-4eb5-910a-39078165f385 | 2026-10-28 | Warnings | R16CO5Y76E |
| QUALITY CHOICE Anti-Nausea | DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 68207fa3-3f69-4405-9191-be702e1bf520 | 2026-10-27 | Warnings | IY9XDZ35W2 |
| Aspirin | ASPIRIN | Walgreen Company | 82cc404b-fcf5-4e48-ab1a-09d8c47f9e04 | 2026-10-27 | Warnings | R16CO5Y76E |
| ASPIRIN | ASPIRIN | Marc Glassman, Inc. | 14cb1d2d-95b8-447e-8d79-e6ec82c0e431 | 2026-10-27 | Warnings | R16CO5Y76E |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | WALGREENS | 07d34e7a-c0c6-f3c4-e063-6294a90aa5c3 | 2026-10-26 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Marlex Pharmaceuticals Inc. | cc7013ea-cf30-6f59-e053-2a95a90a1148 | 2026-10-26 | Warnings | R16CO5Y76E |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | CVS Pharmacy | 9e459853-5951-4ae7-88a6-85b502e9dd41 | 2026-10-26 | Warnings | R16CO5Y76E |
| Excedrin Migraine | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Select Consumer Group | 3caa4adf-abe3-67c3-e063-6294a90a87a4 | 2026-10-24 | Warnings | R16CO5Y76E |
| Bayer Genuine Aspirin | ASPIRIN | Select Consumer Group | 3ca776c2-47ed-5107-e063-6394a90ac5df | 2026-10-24 | Warnings | R16CO5Y76E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.